Entera Appoints Global Pharmaceutical Leader Riccardo Paolo Camisasca, M.D., as Chief Medical Officer Ahead of Planned EB613 Phase 3 Initiation
CompaniesEntera Bio Ltd.
Signals
Every pharma-relevant, de-duplicated event surfaced so far, primary source first. Client-scoped signals are never shown here.
MediBeacon Transdermal GFR System Nominated for 2026 Prix Galien USA Best Medical Technology
CompaniesMediBeacon Inc.AssetsMediBeacon Transdermal GFR SystemLumitrace (relmapirazin) injectionTGFR MonitorTGFR Reusable SensorTGFR Disposable Ring
Board-Certified Vascular and Endovascular Surgeon Performs First Commercial Symvess® Implantation; Cites Bioengineered Blood Vessel as “Revolutionary Advancement”
CompaniesHumacyte, IncAssetsSymvess
Pliant Therapeutics Receives FDA Fast Track Designation for PLN-101095 in Combination with Pembrolizumab for the Treatment of ICI-Refractory Solid Tumors
CompaniesPliant Therapeutics, Inc.AssetsPLN-101095pembrolizumabDiseasesimmune checkpoint inhibitor-refractory solid tumors
Conexeu Sciences Sees a New Category Forming in Medical Aesthetics as Research Turns to Regeneration
CompaniesConexeu Sciences Inc.
Akari Therapeutics Builds Momentum for AKTX-101 with Compelling Urothelial Cancer Data Supporting Differentiated ADC Strategy
CompaniesAkari Therapeutics PlcAssetsAKTX-101Diseasesurothelial cancer
Craif Raises $33M to Accelerate Introduction of Its Urine-Based Cancer Test to the U.S.
CompaniesCraif Inc.Granite-IntegralTauns Co.UnreasonableX&KSKAssetsmiSignalDiseasespancreatic cancer
Trethera Appoints World-Renowned ALS Researcher Dr. Merit Cudkowicz to Scientific Advisory Board
CompaniesTrethera CorporationAssetsTRE-515Diseasesamyotrophic lateral sclerosis (ALS)
BeyondSpring Reports Second-Quarter 2026 Financial Results and Provides Corporate Update
CompaniesBeyondSpring, Inc.
AB Science annonce le succès du règlement-livraison des titres émis dans le cadre de son placement privé de 14,2 millions d’euros annoncé le 10 aout 2026
CompaniesAB Science
AB Science announces the successful settlement and delivery of securities issued as part of its €14.2 million private placement announced on August 10, 2026
CompaniesAB Science
Kamada Declares Cash Dividend of $0.17 Per Share; The Company Reported Record-High Revenue and Profitability for First Six Months of 2026
CompaniesKamada Ltd.
Tilray Medical Accelerates the Commercial Expansion of Tilray Medical-Branded Cannabis Medicines in the UK with First Direct-to-Patient Launch Through Lyphe Clinic and Lyphe Dispensary
CompaniesTilray Brands, Inc.Lyphe ClinicLyphe DispensaryAssetsTilray Medical-branded cannabis flower products
Montauk Brewing Company Expands Its Coastal Footprint with New North Shore Brewpub
CompaniesMontauk Brewing CompanyTilray Brands, Inc.
Novo Nordisk A/S - share repurchase programme
CompaniesNovo Nordisk A/S
Pharmacy Planet surpasses 200,000 YouTube subscribers and highlights the growth of its healthcare education platform
CompaniesPharmacy Planet Limited
Zealand Pharma - Transactions related to share buy-back program (week 33, 2026)
CompaniesZealand Pharma
MD Logic Health Unveils Innovative Daily Multi-Fiber Supplement Featuring Clinically-Proven Solnul Resistant Potato Starch
CompaniesMD Logic HealthAssetsDaily Multi-FiberSolnul Resistant Potato StarchOrganic Acacia GumChicory Root InulinSugar Beet FOS
Zentalis Pharmaceuticals Announces Closing of Underwritten Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
CompaniesZentalis Pharmaceuticals
Coultreon Biopharma Appoints Prista Charuworn, MD as Chief Medical Officer
CompaniesCoultreon BiopharmaGileadAstraZenecaAmgenZai LabAssetsCOL-5671Diseasesautoimmune diseasesulcerative colitispsoriasis